Form 4: Cigna Director Elder Granger Executes Stock Option and Sells Shares Under 10b5-1 Plan

Director Elder Granger exercised stock options and sold shares of Cigna Group (CI) common stock on June 17, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On June 17, 2024, Elder Granger, a director of Cigna Group, executed a transaction involving the company's stock.
• Granger exercised stock options to acquire 547 shares of Cigna common stock at a price of $175.0938 per share.
• Simultaneously, Granger sold 547 shares of Cigna common stock at a price of $331.38 per share.
• These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 13, 2024.
• Following these transactions, Granger directly owns 5,471 shares of Cigna common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction under a pre-existing plan. No indication of positive or negative outlook.

Positives

• The use of a 10b5-1 trading plan suggests a pre-planned and transparent approach to stock transactions, potentially mitigating concerns about insider trading.

Industry Context

Executive stock transactions are common and closely monitored in the healthcare industry. The use of 10b5-1 plans is a standard practice to avoid insider trading accusations.

Comparison to Industry Standards

• Companies like UnitedHealth Group (UNH) and CVS Health (CVS) also see regular Form 4 filings from their executives.
• The volume of shares traded by Elder Granger is relatively small compared to transactions by CEOs or CFOs at larger corporations.
• The use of a 10b5-1 trading plan is a common practice among executives in publicly traded companies to manage their stock holdings.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders, employees, customers, suppliers, or creditors.

Key Dates